Impact of Infectious Diseases on Special Populations

by

Infectious diseases are high-magnitude events that affect public health, particularly those population groups that are vulnerable because of various socio-economic, genetic, and environmental reasons. The responsibility for such diseases then falls heavily on children, the elderly, immunocompromised individuals, and people living in low-income regions. In that respect, awareness of the impacts of infectious diseases on such populations helps revise proper prevention and treatment strategies that will greatly enhance health outcomes. This paper reviews the significant burden of infectious diseases on unique populations, drawing lessons from recent studies and guidelines on various infections like HIV, Zika virus, sexually transmitted infections, pediatric diseases, and ocular diseases caused by HIV. HIV infection and ocular diseases.

HIV infection implies ocular health to a significant degree, especially in the heart. These include infections, including cytomegalovirus retinitis, where, although the incidence has decreased, it still remains an extremely significant pathologic condition among those with an extremely low CD4+ T-cell count. In fact, retinitis due to CMV is the most significant cause of blindness in HIV-infected people and therefore needs continued monitoring and timely intervention. HIV patients are at increased risk of acquiring other ocular infections, such as syphilitic uveitis, which is most likely to complicate the patient’s health management in general. The association of ocular diseases with HIV places much importance on regular eye examinations and timely interventions to prevent blindness.

Yearwise Publication Trend on “infectious diseases”

Find publication trends on relevant topics

Zika Virus and Pregnant Women

The Zika virus presents an enormous risk to pregnant women and the fetus in utero. This could be a vector-borne virus that is very serious at birth, such as microorganisms and other neurodevelopmental disorders. From the Centers for Disease Control and Prevention, the updated guidelines recommend serologic testing of asymptomatic pregnant women with a history of travel to Zika-affected areas. The purpose of this is to enable its early detection and management, which would reduce the risk of congenital Zika syndrome. Appropriate counseling about preventive measures, such as vector control and biting avoidance with repellents, and avoiding travel to high-risk areas should be offered to pregnant women residing in or traveling to areas of ongoing transmission of the Zika virus.

Sexually Transmitted Infections in High-Risk Groups

Sexually transmitted infections, such as Trichomonas vaginitis, Chlamydia trachomatis, and Neisseria gonorrhoeae, continue to be one of the burdens of public health. The infection rates remain high, more so in high-risk groups, which include MSM, sexually active women, and adolescents. On account of their high prevalence, extra-genital infections, particularly in the oropharynx and rectum, require detailed, comprehensive screening beyond the genital tests. Most often, these infections are asymptomatic and, therefore, notoriously difficult to diagnose, increasing the probability of transmission. Incorporating NAATs into the routine STI screening process can drastically improve diagnostic rates and, hence, timely treatment, which in turn reduces the burden of disease.

Pediatric Infectious Diseases

Children, especially those under two years old, are highly susceptible to infectious diseases; bronchiolitis is one such infection that is the major cause of pediatric hospitalization. Bronchiolitis, caused primarily by respiratory syncytial virus, confers significant morbidity and has long-term complications of the respiratory tract. Recent research in this area has focused on identifying the specific pathogens involved in bronchiolitis. Several viruses have different effects on the course of illness and length of hospitalization. This knowledge of the logical factors could therefore guide the treatment protocols and improve the outcomes.

Recent Publications on “infectious diseases”

Find publications on relevant topics

Pathogens of Infection and Long-term Sequelae

This growing body of research suggests that the infectious pathogen type involved in illnesses like bronchiolitis of the lower respiratory tract can very easily affect long-term outcomes, including the development of asthma. For example, rhinovirus-induced infections are significantly associated with an increased incidence of asthma in later childhood. Hence, this association underlines the importance of close monitoring and early interventions in children diagnosed with viral bronchiolitis for the prevention of chronic respiratory conditions.

Challenges in Diagnosing and Treating Infections in Vulnerable Populations

Infectious diseases in vulnerable populations have numerous diagnostic challenges. The presentation of infections in immunocompromised patients, such as in the presence of HIV or during chemotherapy, is atypical and therefore very challenging to diagnose. New and advanced diagnostic techniques, such as molecular multiplex panels, are very useful in identifying the pathogens rapidly in such patients and allowing the timely initiation of appropriate treatments. Diagnostic tools are very instrumental in the management of complicated infections, ensuring good outcomes in patients, and preventing hospital-acquired infections.

Infection Prevention Strategies in Special Populations

Vaccination represents a complex philosophy of vaccination, health education, and targeted screening programs to prevent infectious diseases in certain populations. Vaccination forms a cornerstone for the prevention of diseases such as influenza, pneumococcal infections, and hepatitis B in children, the elderly, and immunocompromised patients. Public health education campaigns are another important component of encouraging awareness regarding preventive measures that include safe sexual practices and mosquito control to avoid the transmission of STIs and vector-borne diseases.

Innovations in Treatment and Management

Recent innovations in treatment protocols and guidelines have made a sea difference in the way infectious diseases are now managed in special populations. For instance, HAART in HIV patients has brought down the opportunistic infection burden by a huge margin, thereby improving overall survival rates. On the other hand, the discovery of rapid diagnostic tests for infections such as candidemia and meningitis has enabled the timely diagnosis and administration of appropriate therapy, which has reduced morbidity and mortality. The integration of newer diagnostic technologies, including next-generation sequencing, into clinical practice can provide an exact identification of the pathogen and, hence, more targeted and effective treatments.

Conclusion

Infectious diseases remain a major health challenge, especially in some subpopulations like children, pregnant women, immunocompromised patients, and those living in resource-poor conditions. Therefore, diagnosis, screening, and new modalities of treatment are necessary for the management and prevention of these diseases. Public health education on vaccination and early interventions can largely reduce the burden of infectious diseases and provide better health outcomes for vulnerable populations. Research and updates of clinical guidelines must be constant to deal with the changing character of infectious disease and guarantee the well-being of all individuals.

References

  1. Wang F, Tian Y, Chen L, Luo R, Sickler J, Liesenfeld O, Chen S. Accurate Detection of Streptococcus pyogenes at the Point of Care Using the cobas Liat Strep A Nucleic Acid Test. Clin Pediatr (Phila). 2017 Oct;56(12):1128-1134. doi: 10.1177/0009922816684602. Epub 2016 Dec 22. PMID: 28006981.
  2. Mathison BA, Pritt BS. Update on Malaria Diagnostics and Test Utilization. J Clin Microbiol. 2017 Jul;55(7):2009-2017. doi: 10.1128/JCM.02562-16. Epub 2017 Apr 12. PMID: 28404673; PMCID: PMC5483902.
  3. Mylonakis E, Clancy CJ, Ostrosky-Zeichner L, Garey KW, Alangaden GJ, Vazquez JA, Groeger JS, Judson MA, Vinagre YM, Heard SO, Zervou FN, Zacharioudakis IM, Kontoyiannis DP, Pappas PG. T2 magnetic resonance assay for the rapid diagnosis of candidemia in whole blood: a clinical trial. Clin Infect Dis. 2015 Mar 15;60(6):892-9. doi: 10.1093/cid/ciu959. Epub 2015 Jan 12. PMID: 25586686.
  4. Chan PA, Robinette A, Montgomery M, Almonte A, Cu-Uvin S, Lonks JR, Chapin KC, Kojic EM, Hardy EJ. Extragenital Infections Caused by Chlamydia trachomatis and Neisseria gonorrhoeae: A Review of the Literature. Infect Dis Obstet Gynecol. 2016;2016:5758387. doi: 10.1155/2016/5758387. Epub 2016 Jun 5. PMID: 27366021; PMCID: PMC4913006.
  5. Durand ML. Bacterial and Fungal Endophthalmitis. Clin Microbiol Rev. 2017 Jul;30(3):597-613. doi: 10.1128/CMR.00113-16. PMID: 28356323; PMCID: PMC5475221.
  6. Kaye S, Sueke H, Romano V, Chen JY, Carnt N, Tuft S, Neal T. Impression membrane for the diagnosis of microbial keratitis. Br J Ophthalmol. 2016 May;100(5):607-10. doi: 10.1136/bjophthalmol-2015-307091. Epub 2015 Sep 16. PMID: 26377412.

Top Experts on “infectious diseases“